In the end, our study proved that ARHGAP11A seemed to be GAP specific for RhoA, and can facilitate HCC malignant progress through Rho-independent pathway, albeit more investigations are still needed to ultimately unravel the regulatory mechanism of ARHGAP11A-Rac1B interaction. The gene discussed is ARHGAP11A; the disease is hepatocellular carcinoma.